Holen Sie sich die Stockscreener-App
41.67
1.56%
-0.66
Vorhandelsmarkt:
41.66
-0.01
-0.02%
Schlusskurs vom Vortag:
$42.33
Offen:
$41.77
24-Stunden-Volumen:
347.49K
Relative Volume:
0.58
Marktkapitalisierung:
$1.29B
Einnahmen:
$1.32B
Nettoeinkommen (Verlust:
$110.20M
KGV:
11.77
EPS:
3.5417
Netto-Cashflow:
$148.24M
1W Leistung:
+2.48%
1M Leistung:
-4.12%
6M Leistung:
-22.85%
1J Leistung:
-33.33%
1-Tages-Spanne:
$41.06
$42.78
1-Wochen-Bereich:
$40.17
$43.84
52-Wochen-Spanne:
$35.37
$65.50
Conmed Corp Stock (CNMD) Company Profile
Firmenname
Conmed Corp
Sektor
Branche
Telefon
727-214-2974
Adresse
11311 CONCEPT BOULEVARD, LARGO, NY
Compare CNMD vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
41.67 | 1.31B | 1.32B | 110.20M | 148.24M | 3.5417 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-12 | Herabstufung | Needham | Buy → Hold |
| 2025-04-28 | Herabstufung | Stifel | Buy → Hold |
| 2025-02-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-02-01 | Bestätigt | Needham | Buy |
| 2023-05-22 | Eingeleitet | CL King | Buy |
| 2023-03-27 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-03-21 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2021-10-06 | Hochstufung | Needham | Hold → Buy |
| 2021-07-15 | Eingeleitet | UBS | Buy |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2019-11-26 | Herabstufung | Needham | Buy → Hold |
| 2019-11-12 | Eingeleitet | JP Morgan | Overweight |
| 2019-10-31 | Bestätigt | Needham | Buy |
| 2019-10-04 | Bestätigt | Needham | Buy |
| 2019-08-22 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2019-04-18 | Eingeleitet | Stifel | Buy |
| 2019-04-16 | Bestätigt | Needham | Buy |
| 2019-01-23 | Bestätigt | Needham | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Equal Weight |
| 2018-08-07 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-04-26 | Bestätigt | Needham | Buy |
| 2018-02-01 | Bestätigt | Needham | Buy |
| 2017-07-27 | Bestätigt | Needham | Buy |
| 2017-04-27 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2017-04-27 | Bestätigt | Needham | Buy |
| 2016-11-18 | Bestätigt | Needham | Buy |
| 2016-07-28 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2016-04-28 | Bestätigt | Needham | Buy |
| 2015-10-22 | Bestätigt | Northland Capital | Market Perform |
Alle ansehen
Conmed Corp Aktie (CNMD) Neueste Nachrichten
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now - Finviz
CONMED (NYSE:CNMD) Upgraded at Zacks Research - Defense World
A Look At CONMED (CNMD) Valuation After Earnings And Growth In Key Surgical Segments - simplywall.st
CONMED (NYSE:CNMD) Upgraded to Hold at Zacks Research - MarketBeat
5 Must-Read Analyst Questions From CONMED's Q4 Earnings Call - Finviz
5 Essential Analyst Inquiries from CONMED’s Fourth Quarter Earnings Discussion - Bitget
Earnings call transcript: CONMED Q4 2025 beats EPS forecasts, stock dips - Investing.com
5 Must-Read Analyst Questions From CONMED’s Q4 Earnings Call - Yahoo Finance
Assessing CONMED (CNMD) Valuation After Q4 Results And Surgical Portfolio Shift - Yahoo Finance UK
Street Watch: Should I trade or invest in Taboolacom Ltd Equity Warrant2025 Pullback Review & Long-Term Growth Portfolio Plans - baoquankhu1.vn
CONMED Q4 Earnings Call Highlights - Defense World
Conmed Corporation stock hits 52-week low at 38.05 USD By Investing.com - Investing.com Nigeria
CONMED Stock Up Post Q4 Earnings and Revenue Beat, Gross Margin Up - Yahoo Finance
Conmed Corporation stock hits 52-week low at 38.05 USD - Investing.com
CNMD Q4 Deep Dive: Ortho Outperformance and Strategic Refocusing Shape 2026 Outlook - Finviz
CONMED Corporation (NYSE:CNMD) Q4 2025 Earnings Call Transcript - Insider Monkey
What Analysts Are Saying About Conmed Stock - Benzinga
Conmed Corp (CNMD) Q4 2025 Earnings Call Highlights: Strong Orthopedic Sales Drive Growth ... - Yahoo Finance
CONMED Corp shares slip after Q4 earnings beat, cautious guidance - AlphaStreet News -
Compared to Estimates, Conmed (CNMD) Q4 Earnings: A Look at Key Metrics - Yahoo Finance
CONMED Q4 2025 presentation slides: Strong international growth drives earnings beat - Investing.com
CONMED (CNMD) Q4 2025 Earnings Call Transcript - AOL.com
CONMED Q4 Adjusted Earnings, Revenue Rise; 2026 Guidance Set - marketscreener.com
Earnings call transcript: CONMED beats Q4 2025 estimates, stock dips - Investing.com
Conmed: Q4 Earnings Snapshot - kare11.com
(CNMD) CONMED Expects 2026 Revenue Range $1.35B-$1.38B, vs. FactSet Est of $1.38B - marketscreener.com
(CNMD) CONMED Expects 2026 Adjusted Earnings Range $4.30-$4.45, vs. FactSet Est of $4.50 - marketscreener.com
CONMED (NYSE:CNMD) Beats Q4 CY2025 Sales Expectations, Stock Soars - Finviz
Conmed: Fourth Quarter Financial Highlights - Bitget
Conmed Corp. Profit Retreats In Q4 - Nasdaq
Earnings Flash (CNMD) CONMED Corporation Reports Q4 Revenue $373.2M, vs. FactSet Est of $366.9M - marketscreener.com
Is There Now An Opportunity In CONMED (CNMD) After Prolonged Share Price Weakness - Yahoo Finance
A Glimpse of Conmed's Earnings Potential - Benzinga
CONMED Earnings: What To Look For From CNMD - Finviz
Analyst Upgrade: What is CONMED Corporations market positionQuarterly Trade Review & Precise Entry and Exit Recommendations - baoquankhu1.vn
Will CONMED Corporation outperform small cap indexes2025 Biggest Moves & Growth-Oriented Investment Plans - bollywoodhelpline.com
SG Americas Securities LLC Acquires 61,860 Shares of CONMED Corporation $CNMD - MarketBeat
$CNMD stock is down 9% today. Here's what we see in our data. - Quiver Quantitative
CONMED (NYSE:CNMD) Issues FY 2026 Earnings Guidance - MarketBeat
Conmed CorpPrelim Outlook FY 2026 Total Reported Revenue $1,345 Million To $1,375 MillionPresentation - TradingView — Track All Markets
3 Reasons to Sell CNMD and 1 Stock to Buy Instead - Yahoo Finance
Peregrine Capital Management LLC Has $58,000 Stake in CONMED Corporation $CNMD - MarketBeat
CONMED (NYSE:CNMD) Stock Price Down 4.6% – What’s Next? - Defense World
Conmed's chief information officer sells $16,796 in common stock - MSN
A Look At CONMED (CNMD) Valuation After CFO Transition Plans And 2025 Guidance Reaffirmation - Yahoo Finance
CONMED (NYSE:CNMD) Stock Price Down 4.6%Time to Sell? - MarketBeat
CONMED CFO Todd Garner to step down in March 2026 - Investing.com
CONMED Corp Announces CFO Transition - TradingView — Track All Markets
CONMED (NYSE: CNMD) details CFO Todd Garner’s exit terms and transition plan - Stock Titan
CONMED changes its finance chief but keeps 2025 goals on track - Stock Titan
Tech Rally: What technical signals suggest for CONMED Corporation stockCPI Data & Target Return Focused Picks - Улправда
Finanzdaten der Conmed Corp-Aktie (CNMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):